Background/Aim: High-grade gliomas have a poor prognosis despite standard treatment.
The aim of the study was to identify new prognostic factors to select patients who need more …

Background The purpose of the present study was to analyze the recurrence pattern of high-
grade glioma treated with a multimodal treatment approach and to evaluate whether the MIB …

Background High-grade gliomas (HGGs) are a heterogeneous disease group, with variable
prognosis, inevitably causing deterioration of the quality of life. The estimated 2-year overall …

Background/Aim: Personalized treatment for low-grade gliomas likely improves patient
outcomes. This study aimed to identify predictors of local control and survival. Patients and …

Background/Aim: The prognoses of patients with grade III gliomas require improvement,
which may be achieved with personalized care. We aimed to identify prognostic factors to …

Background A standard post-concomitant radiochemotherapy involving adjuvant
temozolomide (TMZ) was stopped after 6 cycles for high-grade gliomas (HGG). Several …

The involvement of eloquent brain areas may preclude the total/subtotal surgical resection of
diffuse low-grade gliomas (DLGGs). The feasibility and functional tolerance of neoadjuvant …

Background High-grade gliomas (HGG) are highly fatal tumors despite advanced
multimodality management. They are also associated with neurocognitive impairment, both …

Purpose The incidence, risk factors, and outcomes of low-grade glioma patients who
undergo malignant transformation (MT) in the era of temozolomide are not well known. This …

Background: Despite advances in the surgical, radiotherapeutic and chemotherapeutic
fields, the outcome for patients with high-grade gliomas remains poor. Our experience of …